메뉴 건너뛰기




Volumn 40, Issue , 2013, Pages 115-127

Combined oral contraceptives in polycystic ovary syndrome - Indications and cautions

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CYPROTERONE ACETATE; DESOGESTREL; DIENOGEST; DROSPIRENONE; ETHINYLESTRADIOL; ETYNODIOL DIACETATE; LEVONORGESTREL; MESTRANOL; NORETHISTERONE; NORETHISTERONE ACETATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; SEX HORMONE BINDING GLOBULIN; CARBOHYDRATE; GLUCOSE; INSULIN; LIPID;

EID: 84870260938     PISSN: 03013073     EISSN: 16623762     Source Type: Book Series    
DOI: 10.1159/000341823     Document Type: Article
Times cited : (18)

References (35)
  • 2
    • 38149061019 scopus 로고    scopus 로고
    • Oral contraceptives in polycystic ovary syndrome: Risk-benefit assessment
    • Yildiz BO: Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment. Semin Reprod Med 2008;26:111-120.
    • (2008) Semin Reprod Med , vol.26 , pp. 111-120
    • Yildiz, B.O.1
  • 5
    • 77953121511 scopus 로고    scopus 로고
    • Mechanisms of estrogeninduced venous thromboembolism
    • Tchaikovski SN, Rosing J: Mechanisms of estrogeninduced venous thromboembolism. Thromb Res 2010;126:5-11.
    • (2010) Thromb Res , vol.126 , pp. 5-11
    • Tchaikovski, S.N.1    Rosing, J.2
  • 6
    • 0033014691 scopus 로고    scopus 로고
    • Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives
    • Harris GM, Stendt CL, Vollenhoven BJ, Gan TE, Tipping PG: Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives. Am J Hematol 1999;60:175-180.
    • (1999) Am J Hematol , vol.60 , pp. 175-180
    • Harris, G.M.1    Stendt, C.L.2    Vollenhoven, B.J.3    Gan, T.E.4    Tipping, P.G.5
  • 8
    • 69949103268 scopus 로고    scopus 로고
    • The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: Results of the MEGA case-control study
    • van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR: The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009; 339:b2921.
    • (2009) BMJ , vol.339
    • Van Hylckama Vlieg, A.1    Helmerhorst, F.M.2    Vandenbroucke, J.P.3    Doggen, C.J.4    Rosendaal, F.R.5
  • 9
    • 79958149914 scopus 로고    scopus 로고
    • Estrogen and thrombosis: Controversies and common sense
    • DeLoughery TG: Estrogen and thrombosis: controversies and common sense. Rev Endocr Metab Disord 2011;12:77-84.
    • (2011) Rev Endocr Metab Disord , vol.12 , pp. 77-84
    • Deloughery, T.G.1
  • 11
    • 0142122810 scopus 로고    scopus 로고
    • Oral contraceptives use and the risk of myocardial infarction: A meta-analysis
    • 7
    • Khader YS, Rice J, John L, Abueita O: Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception 2003;68:11-1 7.
    • (2003) Contraception , vol.68 , pp. 11-21
    • Khader, Y.S.1    Rice, J.2    John, L.3    Abueita, O.4
  • 12
    • 23044493043 scopus 로고    scopus 로고
    • Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: A meta-analysis
    • Baillargeon JP, McClish DK, Essah PA, Nestler JE: Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab 2005;90:3863-3870.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 3863-3870
    • Baillargeon, J.P.1    McClish, D.K.2    Essah, P.A.3    Nestler, J.E.4
  • 14
    • 33646491436 scopus 로고    scopus 로고
    • Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: Data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation
    • Merz CN, Johnson BD, Berga S, Braunstein G, Reis SE, Bittner V: Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Fertil Steril 2006; 85:1425-1431.
    • (2006) Fertil Steril , vol.85 , pp. 1425-1431
    • Merz, C.N.1    Johnson, B.D.2    Berga, S.3    Braunstein, G.4    Reis, S.E.5    Bittner, V.6
  • 15
    • 79958137401 scopus 로고    scopus 로고
    • Metabolic effects of contraceptive steroids
    • Sitruk-Ware R, Nath A: Metabolic effects of contraceptive steroids. Rev Endocr Metab Disord 2011;12: 63-75.
    • (2011) Rev Endocr Metab Disord , vol.12 , pp. 63-75
    • Sitruk-Ware, R.1    Nath, A.2
  • 16
    • 0036598136 scopus 로고    scopus 로고
    • Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: The CARDIA Study. Coronary Artery Risk Development in Young Adults
    • Kim C, Siscovick DS, Sidney S, Lewis CE, Kiefe CI, Koepsell TD: Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: the CARDIA Study. Coronary Artery Risk Development in Young Adults. Diabetes Care 2002;25:1027-1032.
    • (2002) Diabetes Care , vol.25 , pp. 1027-1032
    • Kim, C.1    Siscovick, D.S.2    Sidney, S.3    Lewis, C.E.4    Kiefe, C.I.5    Koepsell, T.D.6
  • 19
    • 84155163090 scopus 로고    scopus 로고
    • Consensus on women's health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRMSponsored 3rd PCOS Consensus Workshop Group
    • e25
    • Fauser BC, Tarlatzis BC, Rebar RW, et al: Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRMSponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97:28-38, e25.
    • Fertil Steril 2012 , vol.97 , pp. 28-38
    • Fauser, B.C.1    Tarlatzis, B.C.2    Rebar, R.W.3
  • 20
    • 77954870760 scopus 로고    scopus 로고
    • Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis
    • Moran LJ, Misso ML, Wild RA, Norman RJ: Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010;16:347-363.
    • (2010) Hum Reprod Update , vol.16 , pp. 347-363
    • Moran, L.J.1    Misso, M.L.2    Wild, R.A.3    Norman, R.J.4
  • 21
    • 77449124834 scopus 로고    scopus 로고
    • Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis
    • Mak W, Dokras A: Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis. Semin Thromb Hemost 2009;35:613-620.
    • (2009) Semin Thromb Hemost , vol.35 , pp. 613-620
    • Mak, W.1    Dokras, A.2
  • 24
    • 33745183175 scopus 로고    scopus 로고
    • Cardiovascular risk in women with polycystic ovary syndrome
    • Orio F, Palomba S, Colao A: Cardiovascular risk in women with polycystic ovary syndrome. Fertil Steril 2006;86(suppl 1):S20-S21.
    • (2006) Fertil Steril , vol.86 , Issue.SUPPL. 1
    • Orio, F.1    Palomba, S.2    Colao, A.3
  • 25
    • 0038307320 scopus 로고    scopus 로고
    • Polycystic ovary syndrome and cardiovascular disease: A premature association?
    • Legro RS: Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 2003;24:302-312.
    • (2003) Endocr Rev , vol.24 , pp. 302-312
    • Legro, R.S.1
  • 26
    • 0028888951 scopus 로고
    • Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome
    • Falsetti L, Pasinetti E: Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 1995;74:56-60.
    • (1995) Acta Obstet Gynecol Scand , vol.74 , pp. 56-60
    • Falsetti, L.1    Pasinetti, E.2
  • 28
    • 78650715566 scopus 로고    scopus 로고
    • The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: A systematic review and meta-analysis of observational studies
    • Halperin IJ, Kumar SS, Stroup DF, Laredo SE: The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies. Hum Reprod 2011;26:191-201.
    • (2011) Hum Reprod , vol.26 , pp. 191-201
    • Halperin, I.J.1    Kumar, S.S.2    Stroup, D.F.3    Laredo, S.E.4
  • 29
    • 0344286476 scopus 로고    scopus 로고
    • Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
    • Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J: Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-146.
    • (1999) Diabetes Care , vol.22 , pp. 141-146
    • Ehrmann, D.A.1    Barnes, R.B.2    Rosenfield, R.L.3    Cavaghan, M.K.4    Imperial, J.5
  • 30
    • 21244465167 scopus 로고    scopus 로고
    • Changes in glucose tolerance over time in women with polycystic ovary syndrome: A controlled study
    • Legro RS, Gnatuk CL, Kunselman AR, Dunaif A: Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 2005;90:3236-3242.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 3236-3242
    • Legro, R.S.1    Gnatuk, C.L.2    Kunselman, A.R.3    Dunaif, A.4
  • 32
    • 84865472733 scopus 로고    scopus 로고
    • Polycystic ovary syndrome is a risk factor for type 2 diabetes: Results from a longterm prospective study
    • Epub ahead of print
    • Gambineri A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, Pasquali R: Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a longterm prospective study. Diabetes 2012, Epub ahead of print.
    • (2012) Diabetes
    • Gambineri, A.1    Patton, L.2    Altieri, P.3    Pagotto, U.4    Pizzi, C.5    Manzoli, L.6    Pasquali, R.7
  • 33
    • 34447096147 scopus 로고    scopus 로고
    • Metformin versus oral contraceptive pill in polycystic ovary syndrome: A Cochrane review
    • Costello MF, Shrestha B, Eden J, Johnson NP, Sjoblom P: Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review. Hum Reprod 2007;22:1200-1209.
    • (2007) Hum Reprod , vol.22 , pp. 1200-1209
    • Costello, M.F.1    Shrestha, B.2    Eden, J.3    Johnson, N.P.4    Sjoblom, P.5
  • 34
    • 56549114144 scopus 로고    scopus 로고
    • The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: An updated systematic review
    • Jing Z, Liang-Zhi X, Tai-Xiang W, Ying T, Yu-Jian J: The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review. Gynecol Endocrinol 2008;24:590-600.
    • (2008) Gynecol Endocrinol , vol.24 , pp. 590-600
    • Jing, Z.1    Liang-Zhi, X.2    Tai-Xiang, W.3    Ying, T.4    Yu-Jian, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.